SQZ Biotech Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 150

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 4

SQZ Biotech General Information

Description

SQZ Biotechnologies Co is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ has the ability to deliver multiple materials into many patient cell types to engineer what it believes to be an unprecedented range of potential therapeutics for a range of diseases. The company has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and potentially improve the patient experience over existing cell therapy approaches, with accelerated production timelines under 24 hours and the elimination of preconditioning and lengthy hospital stays.

Contact Information

Website
www.sqzbiotech.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 200 Arsenal Yards Boulevard
  • Watertown, MA 02472
  • United States
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Acquirer
STEMCELL Technologies
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 200 Arsenal Yards Boulevard
  • Watertown, MA 02472
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SQZ Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Merger/Acquisition 04-Mar-2024 Completed Generating Revenue
12. 2PO 12-Feb-2021 Completed Generating Revenue
11. IPO 30-Oct-2020 Completed Generating Revenue
10. Accelerator/Incubator Completed Generating Revenue
9. Later Stage VC (Series D) 18-May-2020 Completed Generating Revenue
8. Later Stage VC 18-Dec-2019 Completed Generating Revenue
7. Later Stage VC (Series C) 14-Aug-2018 Completed Generating Revenue
6. Early Stage VC (Series B) 01-Dec-2016 Completed Generating Revenue
5. Grant 01-Jan-2016 $3.82M $6.38M Completed Startup
4. Early Stage VC (Series A) 28-Jul-2015 $5.08M $6.38M Completed Startup
To view SQZ Biotech’s complete valuation and funding history, request access »

SQZ Biotech Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D
Series C
Series B
Series A 1,490,035 $0.001000 6% $3.41 $3.41 1x $3.41 6.92%
Seed 350,858 $0.001000 $2.85 $2.85 1x $2.85 1.63%
To view SQZ Biotech’s complete cap table history, request access »

SQZ Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
SQZ Biotechnologies Co is a clinical-stage biotechnology company developing transformative cell therapies for patients w
Drug Delivery
Watertown, MA
150 As of 2026

Farmington, CT
 

Rockville, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SQZ Biotech Competitors (15)

One of SQZ Biotech’s 15 competitors is CaroGen, a Venture Capital-Backed company based in Farmington, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CaroGen Venture Capital-Backed Farmington, CT
Regenxbio Formerly VC-backed Rockville, MD
Meditope Biosciences Formerly VC-backed Pasadena, CA
Onconova Therapeutics Formerly VC-backed Newtown, PA
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 15 competitors. Get the full list »

SQZ Biotech Patents

  • 97

    Total Documents Applications and Grants

  • Total Patents Families

  • 19

    Granted

  • 32

    Pending

  • Expiring in next 12 mo

SQZ Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024026491-A2 Enhanced antigen presenting cell formulations Inactive 28-Jul-2022
WO-2024026491-A3 Enhanced antigen presenting cell formulations Inactive 28-Jul-2022
WO-2024026492-A1 Methods for treating cancer with enhanced antigen presenting cells Inactive 28-Jul-2022
WO-2024026490-A1 Polynucleotides encoding linked antigens and uses thereof Inactive 28-Jul-2022
WO-2023230253-A1 Cartridges and devices for use in a system for delivery of a payload into a cell Inactive 27-May-2022 C12M23/42
To view SQZ Biotech’s complete patent history, request access »

SQZ Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SQZ Biotech Former Investors (26)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alumni Ventures Venture Capital Minority
Ascent Venture Partners Venture Capital Minority
Angel (individual) Minority
Bridger Healthcare Partners Venture Capital Minority
C2I Accelerator Accelerator/Incubator
You’re viewing 5 of 26 investors. Get the full list »

Ready to get started?

Request a free trial

SQZ Biotech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view SQZ Biotech’s complete esg history, request access »

SQZ Biotech FAQs

  • When was SQZ Biotech founded?

    SQZ Biotech was founded in 2013.

  • Where is SQZ Biotech headquartered?

    SQZ Biotech is headquartered in Watertown, MA.

  • What is the size of SQZ Biotech?

    SQZ Biotech has 150 total employees.

  • What industry is SQZ Biotech in?

    SQZ Biotech’s primary industry is Drug Delivery.

  • Is SQZ Biotech a private or public company?

    SQZ Biotech is a Private company.

  • What is SQZ Biotech’s current revenue?

    The current revenue for SQZ Biotech is .

  • How much funding has SQZ Biotech raised over time?

    SQZ Biotech has raised $298M.

  • Who are SQZ Biotech’s investors?

    Alumni Ventures, Ascent Venture Partners, , Bridger Healthcare Partners, and C2I Accelerator are 5 of 26 investors who have invested in SQZ Biotech.

  • Who are SQZ Biotech’s competitors?

    CaroGen, Regenxbio, Meditope Biosciences, Onconova Therapeutics, and CytomX Therapeutics are some of the 15 competitors of SQZ Biotech.

  • When was SQZ Biotech acquired?

    SQZ Biotech was acquired on 04-Mar-2024.

  • Who acquired SQZ Biotech?

    SQZ Biotech was acquired by STEMCELL Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process